| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/28/2010 | CN1524579B Composite viscoelastic preparation |
| 04/28/2010 | CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN101698852A Protein or polypeptide with function of CD137L, and gene and application thereof |
| 04/28/2010 | CN101698682A Double-functional fusion protein based on antibacterial peptide, preparation method and applicaitoin thereof |
| 04/28/2010 | CN101698681A Chimeric polypeptide with dual-targeting function and applications thereof |
| 04/28/2010 | CN101698678A Silkworm antibacterial peptide, cDNA sequence thereof and application thereof |
| 04/28/2010 | CN101698103A Medicine composite for treating B type diabetes |
| 04/28/2010 | CN101698099A Traditional Chinese medicine for treating diabetes |
| 04/28/2010 | CN101698098A Preparation method of sustained release preparation of phytohemagglutinin |
| 04/28/2010 | CN101697979A Officinal fungus mycelium extract and preparation method thereof |
| 04/28/2010 | CN101697971A Rehabilitation therapy method for lung cancer |
| 04/27/2010 | USRE41288 increasing insulinotropic response in ischemia and treating reperfusion and injured brain cells after an ischemic event by administering glucagon-like peptide-1 and a pharmaceutical carrier for a time sufficient and under conditions effective to increase insulinotropic response which produces insulin |
| 04/27/2010 | USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors |
| 04/27/2010 | USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein |
| 04/27/2010 | USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied |
| 04/27/2010 | USRE41276 Strains of bacteria characterized by exhibiting a 7 alpha-dehydroxylase activity of less than 50%, and bile acid deconjugation activity of less than 50%, and descendants, mutants and derivatives thereof; for preventing and treating diseases associated with or caused by an altered metabolism of bile acids |
| 04/27/2010 | US7705196 sFRP expression enhancing agent |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705140 DNAs encoding TNF receptor family members |
| 04/27/2010 | US7705134 immunoglobulins; fibronectins; drug screening |
| 04/27/2010 | US7705129 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 04/27/2010 | US7705128 Comprises interleukin-1 zeta polypeptides (IL-1) for diagnosis, prevention and treatment of tumors, allergies and infectious diseases |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705119 A Deltorphin-E polypeptide having a specific amino acid sequence and acarrier; antishock agents; opiod receptor agonists; nucleotide sequence;hypertensive agents; antiinflammatory agents; antiischemic agents; surgery;restoring perfusion to organs and tissues; prophylaxis |
| 04/27/2010 | US7705118 Methods for preparing internally constrained peptides and peptidomimetics |
| 04/27/2010 | US7705117 EGFH2 genes and gene products |
| 04/27/2010 | US7705116 Method and system for solubilizing protein |
| 04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
| 04/27/2010 | US7705016 administering small molecule capable of inhibiting CPT1(carnitine palmitoyl transferase1) is 2-tetradecylglydate (TDGA) or (R)-N-(tetradecylcarbamoyl)-aminocarnitine |
| 04/27/2010 | US7705012 7-iminomethyl or 7-oxymethyl camptothecin derivatives conjugated, possibly by means of suitable spacers, to cyclopeptide derivatives containing the arginine-glycine-aspartic acid sequence; anticarcinogenic, antimetastasis agent; high affinity for integrin receptors alpha v beta 3 and alpha v beta 5 |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7704987 Metal complex based on 1,10-phenanthroline binds to histidine of the N-terminal loop of the peptide in such a way that the N-terminal loop (amino acid residues 1-15) is blocked or destabilised to inhibit the binding copper, zinc and iron compounds -ones of magnesium /calcium; Alzheimer,s disease |
| 04/27/2010 | US7704969 Transfection complexes |
| 04/27/2010 | US7704968 treating cancer with antisense oligonucleotide complementary to a region of a nuclear factor- kappa B(NF- kappa B) subunit mRNA, contains phosphate backbone chemically modified; leukemia, fibroblast cancer; inhibiting septic shock; biocompatibility with no side effect |
| 04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
| 04/27/2010 | US7704964 Methods and compounds for the targeting of protein to exosomes |
| 04/27/2010 | US7704962 Small oligonucleotides with anti-tumor activity |
| 04/27/2010 | US7704958 Methods and compositions for inhibiting apoptosis using serine protease inhibitors |
| 04/27/2010 | US7704957 For therapy of AIDS |
| 04/27/2010 | US7704956 Glutathione-based delivery system |
| 04/27/2010 | US7704955 polypeptide which can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals |
| 04/27/2010 | US7704954 Method and carrier complexes for delivering molecules to cells |
| 04/27/2010 | US7704953 construction, expression, and selection of genes that encode novel Trp cage polypeptides with desirable cell and/or tissue binding properties, as well as the novel Trp cage polypeptides themselves; phage display libraries are useful for isolating target specific peptides |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704951 administering as an active ingredient selenoprotein P and/or a peptide fragment or a series of peptide fragments derived from said protein; suitably applicable to diseases with decrease in motor function |
| 04/27/2010 | US7704950 Methods of using soluble heterodimeric cytokine receptor |
| 04/27/2010 | US7704949 Perioperative injection of a polypeptide preferential inhibitor of kallikrein, rather than aprotinin, for cardiopulmonary bypass surgery or coronary artery bypass grafting |
| 04/27/2010 | US7704947 Methods and compositions for the treatment of gastrointestinal disorders |
| 04/27/2010 | US7704946 Using beta-amyloid, or fragment thereof; anticonvulsants; antiepileptic agents |
| 04/27/2010 | US7704945 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 04/27/2010 | US7704944 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis |
| 04/27/2010 | US7704943 Angiogenesis inhibitors; using transglutaminase; antitumor agents; anticancer agents |
| 04/27/2010 | US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties |
| 04/27/2010 | US7704737 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination |
| 04/27/2010 | US7704711 Human protein kinases and uses therefor |
| 04/27/2010 | US7704710 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 04/27/2010 | US7704709 Recombinant cytokine protein for use in treatment of leukemia |
| 04/27/2010 | US7704701 Diagnosis of prostate cancer with SPAS-1 cancer antigen |
| 04/27/2010 | US7704685 In vivo production of a clostridial neurotoxin light chain peptide |
| 04/27/2010 | US7704525 Lipid microparticles by cryogenic micronization |
| 04/27/2010 | US7704524 Transdermal botulinum toxin administration for the treatment of spastic muscle pain |
| 04/27/2010 | US7704514 Vaccines |
| 04/27/2010 | US7704512 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/27/2010 | US7704511 Combination of local botulinum toxin and oral triptan drug administration; preventing overuse; reducing pain sensory output |
| 04/27/2010 | US7704507 Anticancer vaccine and diagnostic methods and reagents |
| 04/27/2010 | US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 04/27/2010 | US7704505 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 04/27/2010 | US7704501 Antibodies binding to human ataxin-1-like polypeptide |
| 04/27/2010 | US7704500 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 04/27/2010 | US7704499 Antibody against fragments of apo-lipoprotein B; for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases |
| 04/27/2010 | US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 04/27/2010 | US7704492 providing recombinant adeno-associated virus (AAV) virion which comprises an AAV vector, AAV vector comprising selected gene operably linked to control elements capable of directing in vivo transcription and translation of selected gene and introducing recombinant AAV virion into muscle cell or tissue |
| 04/27/2010 | US7704490 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2435552C A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 04/27/2010 | CA2400570C Heterologous expression of neisserial proteins |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2321149C Antitumor agents |
| 04/27/2010 | CA2297660C Production of human mutated proteins in human cells by means of homologous recombination |
| 04/27/2010 | CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/27/2010 | CA2278465C Diagnosis and treatment of myocardial failure |
| 04/27/2010 | CA2245379C Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo |
| 04/27/2010 | CA2203758C Compositions for the detection of proteases in biological samples and methods of use thereof |
| 04/27/2010 | CA2195653C Cells bearing cd4 decoy receptors and related molecules and methods |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/27/2010 | CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease |
| 04/24/2010 | CA2689482A1 Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 04/24/2010 | CA2681236A1 Methods and compositions for treatment of fibrosis |
| 04/23/2010 | CA2643529A1 Method and composition for enhancement of male erectile function |
| 04/22/2010 | WO2010045586A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 04/22/2010 | WO2010045229A2 Protecting and repairing cartilage and musculoskeletal soft tissues |